Key Insights

Highlights

Success Rate

100% trial completion (above average)

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT02730611Completed

Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma

Showing all 1 trials

Research Network

Active Sponsors

  • Centre International de la Recherche sur le Cancer1
  • Assistance Publique - Hôpitaux de Paris1
  • Institut National de la Santé Et de la Recherche Médicale, France1
  • National Cancer Institute, France1

Top Investigators

Related Conditions

  • Vertical Sleeve Gastrectomy1
  • Hepatocellular Carcinoma1
  • Metabolic Syndrome1
  • Cholangiocarcinoma1
  • Morbid Obesity1

Activity Timeline